Cite Filings / STLN / 0001628280-22-025471

Feed Companies Filings Check

Sign in

424B3

Prospectus

Starling Oncology, Inc. Filed 2022-09-26 Acc 0001628280-22-025471

Documents 1

424B3 Prospectus , toi-dfconvertiblenote424b3.htm

Around this filing

2022-11-10 424B3 Prospectus
2022-09-26 EFFECT Notice of Effectiveness
2022-09-26 424B3 Prospectus
2022-09-26 SC 13D/A Beneficial Ownership Report
2022-09-26 4 10% owner sold 25,614 shares at an average $4.33 ($110,826)
2022-09-23 3 Initial Statement of Ownership
2022-09-22 424B3 Prospectus

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading toi-dfconvertiblenote424b3.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…